These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 30957161)
1. Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis. Tariq R; Pardi DS; Bartlett MG; Khanna S Clin Infect Dis; 2019 Apr; 68(8):1351-1358. PubMed ID: 30957161 [TBL] [Abstract][Full Text] [Related]
2. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622 [TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Kassam Z; Lee CH; Yuan Y; Hunt RH Am J Gastroenterol; 2013 Apr; 108(4):500-8. PubMed ID: 23511459 [TBL] [Abstract][Full Text] [Related]
5. Fecal Microbiota Transplantation and Medical Therapy for Clostridium difficile Infection : Meta-analysis of Randomized Controlled Trials. Singh T; Bedi P; Bumrah K; Gandhi D; Arora T; Verma N; Schleicher M; Rai MP; Garg R; Verma B; Sanaka MR J Clin Gastroenterol; 2022 Nov-Dec 01; 56(10):881-888. PubMed ID: 34516460 [TBL] [Abstract][Full Text] [Related]
6. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial. Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925 [TBL] [Abstract][Full Text] [Related]
7. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Quraishi MN; Widlak M; Bhala N; Moore D; Price M; Sharma N; Iqbal TH Aliment Pharmacol Ther; 2017 Sep; 46(5):479-493. PubMed ID: 28707337 [TBL] [Abstract][Full Text] [Related]
8. Resolution rates in clinical trials for microbiota restoration for recurrent Tariq R; Pardi DS; Khanna S Therap Adv Gastroenterol; 2023; 16():17562848231174293. PubMed ID: 37274301 [TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation in refractory or recurrent Clostridium difficile infection: a real-life experience in a non-academic center. Ponte A; Pinho R; Mota M; Silva J; Vieira N; Oliveira R; Rodrigues J; Sousa M; Sousa I; Carvalho J Rev Esp Enferm Dig; 2018 May; 110(5):311-315. PubMed ID: 29411989 [TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation for recurrent Clostridioides difficile infection. Haber SL; Raney CRK; Larson TL; Lau JP Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis. Tariq R; Syed T; Yadav D; Prokop LJ; Singh S; Loftus EV; Pardi DS; Khanna S J Clin Gastroenterol; 2023 Mar; 57(3):285-293. PubMed ID: 34864789 [TBL] [Abstract][Full Text] [Related]
12. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile. Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of fecal microbiota transplant for recurrent Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis. Cheng F; Huang Z; Li Z; Wei W Rev Esp Enferm Dig; 2022 Sep; 114(9):543-549. PubMed ID: 35510325 [TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis. Hui W; Li T; Liu W; Zhou C; Gao F PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis. Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143 [TBL] [Abstract][Full Text] [Related]
17. Fecal Microbiota Transplantation for Refractory and Recurrent Bang BW; Park JS; Kim HK; Shin YW; Kwon KS; Kwon HY; Baek JH; Lee JS Korean J Gastroenterol; 2017 Apr; 69(4):226-231. PubMed ID: 28449424 [TBL] [Abstract][Full Text] [Related]
18. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial. Jiang ZD; Jenq RR; Ajami NJ; Petrosino JF; Alexander AA; Ke S; Iqbal T; DuPont AW; Muldrew K; Shi Y; Peterson C; Do KA; DuPont HL PLoS One; 2018; 13(11):e0205064. PubMed ID: 30388112 [TBL] [Abstract][Full Text] [Related]
19. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection. Kelly BJ; Tebas P Chest; 2018 Jan; 153(1):266-277. PubMed ID: 28923757 [TBL] [Abstract][Full Text] [Related]
20. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis? Tang G; Yin W; Liu W Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]